Neslihan Cabıoğlu

4.4k total citations
112 papers, 2.8k citations indexed

About

Neslihan Cabıoğlu is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Neslihan Cabıoğlu has authored 112 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 51 papers in Cancer Research and 42 papers in Pathology and Forensic Medicine. Recurrent topics in Neslihan Cabıoğlu's work include Breast Cancer Treatment Studies (49 papers), Breast Lesions and Carcinomas (41 papers) and Breast Implant and Reconstruction (17 papers). Neslihan Cabıoğlu is often cited by papers focused on Breast Cancer Treatment Studies (49 papers), Breast Lesions and Carcinomas (41 papers) and Breast Implant and Reconstruction (17 papers). Neslihan Cabıoğlu collaborates with scholars based in Türkiye, United States and Belgium. Neslihan Cabıoğlu's co-authors include Vahit Özmen, Abdullah İğci, Ayşegül A. Şahin, Mustafa Keçer, Hasan Karanlık, Mahmut Müslümanoğlu, Kristine Broglio, Janet E. Price, Massimo Cristofanilli and Sıtkı Tuzlalı and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Neslihan Cabıoğlu

102 papers receiving 2.6k citations

Peers

Countries citing papers authored by Neslihan Cabıoğlu

Since Specialization

Citations

This map shows the geographic impact of Neslihan Cabıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neslihan Cabıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neslihan Cabıoğlu more than expected).

Fields of papers citing papers by Neslihan Cabıoğlu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neslihan Cabıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neslihan Cabıoğlu. The network helps show where Neslihan Cabıoğlu may publish in the future.

Co-authorship network of co-authors of Neslihan Cabıoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Neslihan Cabıoğlu. A scholar is included among the top collaborators of Neslihan Cabıoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neslihan Cabıoğlu. Neslihan Cabıoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study 2025 ·European Journal of Surgical Oncology ·Neslihan Cabıoğlu, (unknown), Abdullah İğci, Cihan Uras, Onur Dülgeroğlu, Güldeniz Karadeniz Çakmak, Ahmet Sezer, Günay Gürleyik, Mustafa Tükenmez, (unknown), Mahmut Müslümanoğlu, Enver Özkurt, (unknown), Mustafa Ümit Uğurlu, (unknown), (unknown), Vahit Özmen, Bahadır M. Güllüoğlu	1
2	Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study 2025 ·Clinical Breast Cancer ·Neslihan Cabıoğlu, Hasan Karanlık, Vahit Özmen, Mustafa Tükenmez, Abdullah İğci, (unknown), Hande Köksal, (unknown), (unknown), Cihan Uras, Onur Dülgeroğlu, Enver Özkurt, (unknown), Mahmut Müslümanoğlu, (unknown), Ahmet Sezer, Güldeniz Karadeniz Çakmak, (unknown), (unknown), Bahadır M. Güllüoğlu	0
3	Comparison of tumor clipping and marking of skin projection methods in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy: A randomized controlled trial 2025 ·Medicine ·(unknown), (unknown), Neslihan Cabıoğlu, (unknown), Ravza Yılmaz, (unknown), (unknown)	0
4	Idiopathic Granulomatous Mastitis: A Consensus Report on Treatment and Follow-Up Approaches Based on the Turkish Clinical Classification 2025 ·Breast Care ·Mustafa Emiroğlu, Kenan Çetin, Kerim Bora Yılmaz, Mehmet Velidedeoğlu, Sadullah Girgin, Alper Akçan, Hüseyin Özgür Aytaç, (unknown), Hande Köksal, Neslihan Cabıoğlu, Nuh Zafer Cantürk, Bahadır M. Güllüoğlu	0
5	New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer 2024 ·Cancers ·Neslihan Cabıoğlu, Semen Önder, (unknown), (unknown), Gizem Öner, Mustafa Tükenmez, Mahmut Müslümanoğlu, Abdullah İğci, Ahmet Dinççağ, Vahit Özmen, Adnan Aydıner, Pınar Saip, Ekrem Yavuz	1
6	Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy 2024 ·World Journal of Surgical Oncology ·(unknown), (unknown), Neslihan Cabıoğlu, (unknown), Mustafa Tükenmez, Hasan Karanlık, Tolga Özmen, Ravza Yılmaz, (unknown), Semen Önder, (unknown), Duygu Has Şimşek, (unknown), (unknown), Adnan Aydıner, Vahit Özmen, Abdullah İğci	4
7	Pure Tubular Breast Carcinoma: Clinicopathological Characteristics and Clinical Outcomes 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Mustafa Tükenmez, Neslihan Cabıoğlu, (unknown), Vahit Özmen, Mahmut Müslümanoğlu	2
8	Evaluation of Benign Breast Diseases With or Without Atypical Epithelial Hyperplasia Accompanying Radial Scars 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Enver Özkurt, Mustafa Tükenmez, (unknown), (unknown), Semen Önder, Ravza Yılmaz, Mahmut Müslümanoğlu, Abdullah İğci, Vahit Özmen, Neslihan Cabıoğlu	0
9	Surgery for phyllodes tumour of the breast. What should be surgical margins? 2023 ·ANZ Journal of Surgery ·Mustafa Tükenmez, (unknown), Semen Önder, (unknown), Mehmet Velidedeoğlu, Sefa Ergün, Neslihan Cabıoğlu, (unknown)	5
10	Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Semen Önder, Mustafa Tükenmez, Neslihan Cabıoğlu, Seden Küçücük, Mahmut Müslümanoğlu, Vahit Özmen, Pınar Saip, Abdullah İğci, Adnan Aydıner	1
11	Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes 2022 ·SHILAP Revista de lepidopterología ·(unknown), Mustafa Tükenmez, (unknown), Hasan Karanlık, Semen Önder, Vahit Özmen, Neslihan Cabıoğlu, Enver Özkurt, Ravza Yılmaz, Mahmut Müslümanoğlu	1
12	Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up 2022 ·BMC Cancer ·Cihan Uras, Neslihan Cabıoğlu, Fatma Tokat, Özlem Er, Halil Kara, Taner Korkmaz, Nuran Beşe, Ümit İnce	1
13	TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer 2021 ·BMC Cancer ·Neslihan Cabıoğlu, Semen Önder, Gizem Öner, (unknown), Mustafa Tükenmez, Mahmut Müslümanoğlu, Abdullah İğci, Yeşim Eralp, Adnan Aydıner, Pınar Saip, Ekrem Yavuz, Vahit Özmen	18
14	Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment 2020 ·Breast Care ·Hasan Karanlık, Neslihan Cabıoğlu, (unknown), İlker Özgür, (unknown), Adnan Aydıner, Semen Önder, (unknown), Bahadır M. Güllüoğlu	6
15	Comparison of Intermittent Pneumatic Compression with Manual Lymphatic Drainage for Treatment of Breast Cancer-Related Lymphedema 2012 ·Lymphatic Research and Biology ·(unknown), (unknown), İkbal Çavdar, Ayfer Özbaş, Neslihan Cabıoğlu, Beyza Özçınar, Abdullah İğci, Mahmut Müslümanoğlu, Vahit Özmen	47
16	Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer 2007 ·Annals of Oncology ·Neslihan Cabıoğlu, Yun Yun Gong, R. Islam, Kristine Broglio, Nour Sneige, Ayşegül A. Şahin, Ana M. González-Angulo, Paolo Morandi, C Bucana, G. N. Hortobágyi, Massimo Cristofanilli	117
17	Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer 2006 ·Annals of Oncology ·Fabrice André, Neslihan Cabıoğlu, Hazem Assi, Jean‐Christophe Sabourin, Suzette Delaloge, A. Şahin, Kristine Broglio, (unknown), Christophe Combadière, C Bucana, Jean‐Charles Soria, Massimo Cristofanilli	161
18	CXCL-12/Stromal Cell–Derived Factor-1α Transactivates HER2-neu in Breast Cancer Cells by a Novel Pathway Involving Src Kinase Activation 2005 ·Cancer Research ·Neslihan Cabıoğlu, Justin M. Summy, Claudia P. Miller, Nila U. Parikh, Ayşegül A. Şahin, Sıtkı Tuzlalı, Kevin Pumiglia, Gary E. Gallick, Janet E. Price	129
19	Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow 2005 ·Clinical & Experimental Metastasis ·Neslihan Cabıoğlu, Ayşegül A. Şahin, Michèle Doucet, Ekrem Yavuz, Abdullah İğci, Engin Yıldırım, Esin Aktaş Çetin, (unknown), (unknown), Günnur Deniz, Janet E. Price	71
20	Increased False Negative Rates in Sentinel Lymph Node Biopsies in Patients with Multi-Focal Breast Cancer 2002 ·Breast Cancer Research and Treatment ·Vahit Özmen, Mahmut Müslümanoğlu, Neslihan Cabıoğlu, Sıtkı Tuzlalı, (unknown), Abdullah İğci, Mustafa Keçer, (unknown), (unknown)	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact